Comparison of clinical rating scales in genetic frontotemporal dementia within the GENFI cohort

BACKGROUND: Therapeutic trials are now underway in genetic forms of frontotemporal dementia (FTD) but clinical outcome measures are limited. The two most commonly used measures, the Clinical Dementia Rating (CDR)+National Alzheimer’s Disease Coordinating Center (NACC) Frontotemporal Lobar Degenerati...

Descripción completa

Detalles Bibliográficos
Autores principales: Peakman, Georgia, Russell, Lucy L, Convery, Rhian S, Nicholas, Jennifer M, Van Swieten, John C, Jiskoot, Lize C, Moreno, Fermin, Sanchez-Valle, Raquel, Laforce, Robert, Graff, Caroline, Masellis, Mario, Tartaglia, Maria Carmela, Rowe, James B, Borroni, Barbara, Finger, Elizabeth, Synofzik, Matthis, Galimberti, Daniela, Vandenberghe, Rik, de Mendonça, Alexandre, Butler, Chris R, Gerhard, Alex, Ducharme, Simon, Le Ber, Isabelle, Tagliavini, Fabrizio, Santana, Isabel, Pasquier, Florence, Levin, Johannes, Danek, Adrian, Otto, Markus, Sorbi, Sandro, Rohrer, Jonathan D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Neurodegeneration
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785074/
https://www.ncbi.nlm.nih.gov/pubmed/34353857
http://dx.doi.org/10.1136/jnnp-2021-326868

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785074/
https://www.ncbi.nlm.nih.gov/pubmed/34353857
http://dx.doi.org/10.1136/jnnp-2021-326868

Ejemplares similares